Linked Data API

Show Search Form

Search Results

718220
star this property registered interest true more like this
star this property date less than 2017-04-06more like thismore than 2017-04-06
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Social Services: Finance more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords remove filter
star this property question text To ask Her Majesty’s Government, further to the allocation of £2 billion of new money for adult social care to be released by 2019–20, what steps they will take to ensure that (1) local government, and (2) representatives of local government, are fully engaged in the preparation of the Green Paper on the funding of adult social care, so that that those responsible for social care locally are able to contribute to the creation of long-term solutions. more like this
star this property tabling member printed
Lord Porter of Spalding more like this
unstar this property uin HL6720 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2017-04-24more like thismore than 2017-04-24
star this property answer text <p>Following the announcement of the General Election on 8 June, decisions on the future reform and funding of adult social care will be taken by the new Government.</p> more like this
star this property answering member printed Lord O'Shaughnessy more like this
star this property grouped question UIN HL6721 more like this
star this property question first answered
less than 2017-04-24T11:47:47.797Zmore like thismore than 2017-04-24T11:47:47.797Z
star this property answering member
4545
star this property label Biography information for Lord O'Shaughnessy more like this
star this property tabling member
4555
star this property label Biography information for Lord Porter of Spalding more like this
715496
star this property registered interest true more like this
star this property date less than 2017-03-30more like thismore than 2017-03-30
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading NHS: Reorganisation more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords remove filter
star this property question text To ask Her Majesty’s Government whether they intend that rural proofing will be applied to the NHS Sustainability and Transformation Plans. more like this
star this property tabling member printed
Baroness Byford more like this
unstar this property uin HL6457 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2017-04-06more like thismore than 2017-04-06
star this property answer text <p>NHS England is aware of <em>Rural proofing: practical guidance to assess impacts of policies on rural areas</em>, published by the Department for Environment, Food and Rural Affairs in March 2017.</p><p> </p><p>All Sustainability and Transformation Plans (STPs) build on the Five Year Forward View to present an overall strategy for their geographic footprint and identify the three to five key priorities required to realise their vision. This should take account of specific challenges facing each area, which could include a dispersed, rural population.</p><p> </p><p>STPs have been in the public domain for several months. Partner organisations within each area are engaging both rural and urban communities on their plans and, where required by law, consulting on service change.</p><p> </p><p>NHS England and NHS Improvement continue to provide ongoing support to each STP area. In September 2016, they published <em>Engaging Local People: A guide for local areas developing Sustainability and Transformation Plans</em>, which set out how STP areas should reach out to stakeholders in their areas. A copy of the guidance is attached.</p><p> </p><p>The NHS is exploring ways to better adapt health provision for rural areas. For example, the vanguard covering Morecambe Bay Health Community is improving healthcare in a geographically isolated area by using a high definition telemedicine link between a general practitioner (GP) surgery in Millom and the accident and emergency (A&amp;E) department in Barrow-in-Furness. This means when GPs can seek a second opinion as to whether a patient needs intensive treatment or can be treated in the community – they can call through and have an A&amp;E specialist examine the patient. This means that over the 1,000 square miles that Morecambe Bay covers, patients can have access to expert opinion without having to travel further than their nearest GP.</p><p> </p><p>On 31 March, <em>Next steps on the NHS Five Year Forward View</em> was published by NHS England. The document outlined a 10-point care and efficiency plan which will further contribute to improving the health outcomes of those living in rural areas. A copy of this document is attached.</p>
star this property answering member printed Lord O'Shaughnessy more like this
star this property attachment
1
star this property file name engag-local-people-stps.pdf more like this
star this property title Engaging Local People more like this
2
star this property file name NEXT-STEPS-ON-THE-NHS-FIVE-YEAR-FORWARD-VIEW.pdf more like this
star this property title Next Steps on the Five Year Forward View more like this
star this property question first answered
less than 2017-04-06T11:02:39.093Zmore like thismore than 2017-04-06T11:02:39.093Z
star this property answering member
4545
star this property label Biography information for Lord O'Shaughnessy more like this
star this property tabling member
3343
star this property label Biography information for Baroness Byford more like this
718221
star this property registered interest true more like this
star this property date less than 2017-04-06more like thismore than 2017-04-06
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Social Services: Finance more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords remove filter
star this property question text To ask Her Majesty’s Government what will be the terms of reference for the Green Paper on the funding of adult social care; whether those terms of reference will include all adults who require social care; and when they expect to launch the consultation. more like this
star this property tabling member printed
Lord Porter of Spalding more like this
unstar this property uin HL6721 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2017-04-24more like thismore than 2017-04-24
star this property answer text <p>Following the announcement of the General Election on 8 June, decisions on the future reform and funding of adult social care will be taken by the new Government.</p> more like this
star this property answering member printed Lord O'Shaughnessy more like this
star this property grouped question UIN HL6720 more like this
star this property question first answered
less than 2017-04-24T11:47:47.847Zmore like thismore than 2017-04-24T11:47:47.847Z
star this property answering member
4545
star this property label Biography information for Lord O'Shaughnessy more like this
star this property tabling member
4555
star this property label Biography information for Lord Porter of Spalding more like this
717922
star this property registered interest true more like this
star this property date less than 2017-04-05more like thismore than 2017-04-05
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Health Services and Social Services more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords remove filter
star this property question text To ask Her Majesty’s Government what action they are taking to ensure that there are no legislative barriers to the integration of health and social care services and budgets. more like this
star this property tabling member printed
Lord Bradley more like this
unstar this property uin HL6669 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2017-04-20more like thismore than 2017-04-20
star this property answer text <p>The Government is committed to supporting further integration of health and social care. This includes giving due consideration to the need for changes to the legislative framework where this is identified as a barrier to effective integration, and when these changes are in the best interests of the wider health and care system.</p> more like this
star this property answering member printed Lord O'Shaughnessy more like this
star this property question first answered
less than 2017-04-20T14:37:21.093Zmore like thismore than 2017-04-20T14:37:21.093Z
star this property answering member
4545
star this property label Biography information for Lord O'Shaughnessy more like this
star this property tabling member
452
star this property label Biography information for Lord Bradley more like this
714921
star this property registered interest false more like this
star this property date less than 2017-03-29more like thismore than 2017-03-29
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading In Vitro Fertilisation more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords remove filter
star this property question text To ask Her Majesty’s Government, with reference to paragraphs 2.8, 2.9 and 3.17 of the minutes of 9 March 2017 of the Licence Committee of the Human Fertilisation and Embryology Authority, regarding the follow-up of children born following pronuclear transfer between embryos, who is responsible for the follow-up programme in NHS England; what health, genetic and epigenetic parameters are to be measured; what assessment they have made of the potential for long-term medical problems to only become evident after five years of age; whether they intend to conduct follow-ups beyond five years of age; and whether they will place in the Library of the House a copy of the full documented processes that are in place setting out how follow-ups will be carried out. more like this
star this property tabling member printed
Lord Alton of Liverpool more like this
unstar this property uin HL6409 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2017-04-06more like thismore than 2017-04-06
star this property answer text <p>The Human Fertilisation and Embryology Authority has advised that the guidance on the follow up of any children born following mitochondrial donation is set out in paragraph 33.33 in Guidance Note 33 of the Authority’s code of practice. This requires the centre to have a documented process setting out how children born from mitochondrial donation will be followed up, where the patients have consented to follow-up. These should include long-term medical follow-up of the children born. A copy of Guidance Note 33 is attached.</p><p> </p><p>NHS England has agreed funding of £8 million over five years for an evaluative commissioning programme of mitochondrial donation, working closely with the partner organisations such as the Wellcome Trust.</p> more like this
star this property answering member printed Lord O'Shaughnessy more like this
star this property question first answered
less than 2017-04-06T10:57:08.84Zmore like thismore than 2017-04-06T10:57:08.84Z
star this property answering member
4545
star this property label Biography information for Lord O'Shaughnessy more like this
star this property attachment
1
star this property file name CoP_June_2016_GN33.pdf more like this
star this property title Guidance Note 33 more like this
star this property tabling member
738
star this property label Biography information for Lord Alton of Liverpool more like this
714754
star this property registered interest false more like this
star this property date less than 2017-03-28more like thismore than 2017-03-28
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading In Vitro Fertilisation more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords remove filter
star this property question text To ask Her Majesty’s Government, with reference to paragraph 2.8 of the minutes of 9 March 2017 of the Licence Committee of the Human Fertilisation and Embryology Authority (HFEA) regarding babies born following pronuclear transfer between embryos, what procedures are in place to (1) identify whether a child born following pronuclear transfer is born with (a) a mitochondrial disease, (b) a genetic or epigenetic abnormality, (c) a birth defect, or (d) some other adverse outcome, (2) notify the HFEA in cases of any such adverse outcome, and (3) identify any such adverse outcome and notify the HFEA where consent for follow-up has not been granted. more like this
star this property tabling member printed
Lord Alton of Liverpool more like this
unstar this property uin HL6374 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2017-04-06more like thismore than 2017-04-06
star this property answer text <p>The Human Fertilisation and Embryology Authority (HFEA) has advised that, as set out in Guidance Note 33 of the Authority’s code of practice, centres carrying out mitochondrial donation are required to have documented processes in place setting out how the health of children born from mitochondrial donation will be followed up. A copy of Guidance Note 33 is attached.</p><p> </p><p>If the centre becomes aware that any child born as a result of mitochondrial donation has a mitochondrial disease, birth defect, genetic abnormality or if there has been any other adverse outcome, the centre must report this to the HFEA in accordance with the adverse incidents requirements set out in Guidance Note 27 of the code of practice. A copy of Guidance Note 27 is attached.</p> more like this
star this property answering member printed Lord O'Shaughnessy more like this
star this property attachment
1
star this property file name CoP_June_2016_GN33.pdf more like this
star this property title Guidance Note 33 more like this
2
star this property file name CoP_June_2016_GN27.pdf more like this
star this property title Guidance Note 27 more like this
star this property question first answered
less than 2017-04-06T10:53:18.493Zmore like thismore than 2017-04-06T10:53:18.493Z
star this property answering member
4545
star this property label Biography information for Lord O'Shaughnessy more like this
star this property tabling member
738
star this property label Biography information for Lord Alton of Liverpool more like this
714753
star this property registered interest false more like this
star this property date less than 2017-03-28more like thismore than 2017-03-28
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading In Vitro Fertilisation more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords remove filter
star this property question text To ask Her Majesty’s Government, with reference to paragraph 2.3 of the minutes of 9 March 2017 of the Licence Committee of the Human Fertilisation and Embryology Authority, which non-CE marked reagents will be used by Centre 0017 for the purposes of treatment involving pronuclear transfer between embryos to prevent transmission of serious mitochondrial disease; which laboratories will test the non-CE marked reagents for sterility and toxicity; and why non-CE marked reagents are being used. more like this
star this property tabling member printed
Lord Alton of Liverpool more like this
unstar this property uin HL6373 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2017-04-05more like thisremove minimum value filter
star this property answer text <p>The Human Fertilisation and Embryology Authority has advised that it is a condition of a licence that CE marked medical devices must be used wherever possible. In the case of pronuclear transfer, there are no appropriate CE marked reagents, meaning that for treatment to take place, non-CE marked reagents must be used. In this case, the centre must adhere to paragraph 26.5 in Guidance Note 26 of the Authority’s code of practice, which states that if a centre modifies a CE marked product or uses a product “off label”, it must complete a risk assessment and validation to ensure the product is safe. A copy of the Guidance Note 26 is attached.</p> more like this
star this property answering member printed Lord O'Shaughnessy more like this
star this property question first answered
less than 2017-04-05T14:18:48.383Zmore like thismore than 2017-04-05T14:18:48.383Z
star this property answering member
4545
star this property label Biography information for Lord O'Shaughnessy more like this
star this property attachment
1
star this property file name Guidance_Note_26_-_Equipment_and_materials.pdf more like this
star this property title Guidance Note 26 more like this
star this property tabling member
738
star this property label Biography information for Lord Alton of Liverpool more like this
718247
star this property registered interest false more like this
star this property date less than 2017-04-06more like thismore than 2017-04-06
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Mesothelioma more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords remove filter
star this property question text To ask Her Majesty’s Government, further to the Written Answer by Lord O’Shaughnessy on 5 April (HL6371), whether they have made any estimate of the cost of mesothelioma to the NHS; and if so, what. more like this
star this property tabling member printed
Lord Wills more like this
unstar this property uin HL6746 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2017-04-24more like thismore than 2017-04-24
star this property answer text <p>Neither the Department or its arm’s length bodies have made any formal assessment or estimate about the cost of mesothelioma to the National Health Service.</p> more like this
star this property answering member printed Lord O'Shaughnessy more like this
star this property question first answered
less than 2017-04-24T13:26:04.107Zmore like thismore than 2017-04-24T13:26:04.107Z
star this property answering member
4545
star this property label Biography information for Lord O'Shaughnessy more like this
star this property tabling member
260
star this property label Biography information for Lord Wills more like this
718246
star this property registered interest false more like this
star this property date less than 2017-04-06more like thismore than 2017-04-06
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Mesothelioma more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords remove filter
star this property question text To ask Her Majesty’s Government, further to the Written Answer by Lord O’Shaughnessy on 5 April (HL6371), whether anyone collects any data on the cost of mesothelioma to the NHS; and if so, who. more like this
star this property tabling member printed
Lord Wills more like this
unstar this property uin HL6745 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2017-04-24more like thismore than 2017-04-24
star this property answer text <p>While information is not held centrally, individual trusts may capture data relating to the cost of treating mesothelioma patients. However, this information could only be collected at disproportionate cost.</p> more like this
star this property answering member printed Lord O'Shaughnessy more like this
star this property question first answered
less than 2017-04-24T13:25:13.243Zmore like thismore than 2017-04-24T13:25:13.243Z
star this property answering member
4545
star this property label Biography information for Lord O'Shaughnessy more like this
star this property tabling member
260
star this property label Biography information for Lord Wills more like this
717210
star this property registered interest false more like this
star this property date less than 2017-04-03more like thismore than 2017-04-03
star this property answering body
Department of Health more like this
star this property answering dept id 17 more like this
star this property answering dept short name Health more like this
star this property answering dept sort name Health more like this
star this property hansard heading Primodos more like this
unstar this property house id 2 more like this
star this property legislature
25277
star this property pref label House of Lords remove filter
star this property question text To ask Her Majesty’s Government, further to the Written Answer by Lord O’Shaughnessy on 28 March (HL6261), whether they will meet with Marie Lyon and representatives of the Primodos victims support group. more like this
star this property tabling member printed
Lord Alton of Liverpool more like this
unstar this property uin HL6511 more like this
star this property answer
answer
unstar this property is ministerial correction false more like this
star this property date of answer less than 2017-04-06more like thismore than 2017-04-06
star this property answer text <p>One of the terms of reference of the Expert Working Group on Hormonal Pregnancy Tests is to consider what lessons may be learnt for further improving existing regulatory systems to identify, monitor and minimise any adverse effects of medicines in pregnancy. The regulatory, legal and social landscape has changed significantly since hormonal pregnancy tests were on the market; many of these changes have been driven by previous experience. The Group will consider the processes and tools that were available to the United Kingdom regulator when hormonal pregnancy tests were on the market and make recommendations for any changes necessary to further improve the capability of current regulatory systems to identify, monitor and minimise any adverse effects of medicines in pregnancy. This will include all aspects of medicines regulation, from the assessment of safety pre-authorisation to communication of an identified risk.</p><p>There has been continued engagement with the Association for Children Damaged by Hormonal Pregnancy Tests throughout the Expert Working Group review process. I am meeting the All Party Parliamentary Group on Hormone Pregnancy Tests and representatives of the Association in the near future.</p>
star this property answering member printed Lord O'Shaughnessy more like this
star this property grouped question UIN HL6515 more like this
star this property question first answered
less than 2017-04-06T11:03:19.49Zmore like thismore than 2017-04-06T11:03:19.49Z
star this property answering member
4545
star this property label Biography information for Lord O'Shaughnessy more like this
star this property tabling member
738
star this property label Biography information for Lord Alton of Liverpool more like this